Balyasny Asset Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1M | Buy |
+696,125
| New | +$25.1M | 0.04% | 440 |
|
|
2025
Q1 | – | Sell |
-9,100
| Closed | -$274K | – | 2407 |
|
|
2024
Q4 | $274K | Buy |
+9,100
| New | +$274K | ﹤0.01% | 1661 |
|
|
2024
Q3 | – | Sell |
-802,003
| Closed | -$14.3M | – | 2356 |
|
|
2024
Q2 | $14.3M | Buy |
+802,003
| New | +$14.3M | 0.03% | 542 |
|
|
2024
Q1 | – | Sell |
-425,099
| Closed | -$7.26M | – | 2429 |
|
|
2023
Q4 | $7.26M | Buy |
425,099
+278,756
| +190% | +$4.76M | 0.01% | 708 |
|
|
2023
Q3 | $1.22M | Sell |
146,343
-570,621
| -80% | -$4.77M | ﹤0.01% | 1106 |
|
|
2023
Q2 | $17.8M | Buy |
716,964
+361,716
| +102% | +$8.99M | 0.04% | 465 |
|
|
2023
Q1 | $5.34M | Buy |
+355,248
| New | +$5.34M | 0.01% | 776 |
|
|
2022
Q4 | – | Sell |
-10,499
| Closed | -$62K | – | 2740 |
|
|
2022
Q3 | $62K | Buy |
+10,499
| New | +$62K | ﹤0.01% | 1967 |
|
|
2022
Q2 | – | Sell |
-581,587
| Closed | -$5.53M | – | 2692 |
|
|
2022
Q1 | $5.53M | Buy |
581,587
+315,411
| +118% | +$3M | 0.02% | 711 |
|
|
2021
Q4 | $5.06M | Buy |
+266,176
| New | +$5.06M | 0.02% | 710 |
|
|
2020
Q2 | – | Sell |
-25,707
| Closed | -$253K | – | 1308 |
|
|
2020
Q1 | $253K | Buy |
+25,707
| New | +$253K | ﹤0.01% | 889 |
|
|
2018
Q4 | – | Sell |
-102,571
| Closed | -$574K | – | 1564 |
|
|
2018
Q3 | $574K | Buy |
102,571
+50,511
| +97% | +$283K | ﹤0.01% | 1118 |
|
|
2018
Q2 | $685K | Buy |
+52,060
| New | +$685K | ﹤0.01% | 1062 |
|